Posted on 12/30/2021 9:48:13 AM PST by SeekAndFind
Drug maker Novavax (NVAX) recently revealed a bit of good news that gave the stock an extra 3.4% boost in premarket trading last Thursday. The positive momentum did not last long, as the stock was seen drops approaching 6% in trading Thursday morning. The unexpected fluctuations in trading aside, I'm bullish on Novavax. There are some significant potential expansions ahead, and investors have an excellent opportunity to take advantage of these.
The latest news should be more helpful than the market seems willing to accept. Novavax revealed that its COVID-19 vaccine is effective against the Omicron variant. However, as seems to be increasingly the case, the vaccine's protective capabilities increase if you have recently had a booster shot. Trials show that the vaccine has around a 90.4% efficacy rate, which is good, given the number of variants that keep cropping up. Novavax didn't rule out the possibility of targeted vaccines emerging later, though.
Novavax's CEO, Stanley Erck, pointed out that Novavax's COVID-19 vaccine comes with several advantages that vaccines made via messenger RNA (MRNA) do not. For instance, Novavax's COVID-19 vaccine doesn't require super-cold temperatures, like Pfizer's (PFE) and Moderna's (MRNA) need. This means it's easier to transport and easier to store, and offers better shelf life. Erck also pointed out that the Novavax vaccine has fewer side effects than many of its competitors thanks to a “more benign profile.”
(Excerpt) Read more at nasdaq.com ...
They finally found a use for it!...................
Politics 101: Don’t believe everything you read in the newspapers. And infinitely more so, don’t believe everything you read on the internet.
by Jim Robinson
Posted on 12/30/2021, 9:00:07 AM by Jim Robinson
From our things you should’ve learned in school dept:
Don’t believe everything you read in the newspapers, and infinitely more so, “Don’t believe everything you read on the internet. Especially stuff you find on conspiracy sites or blog sites.!”
https://freerepublic.com/focus/f-news/4025405/posts
It seems slack-jawed stupid to have widespread vaccination for a mild variant that poses little threat to most people. Vaccinate the vulnerable if they ask for it, but let omicron do its thing and spread natural immunity. Haven’t they learned anything from the soaring case rates in the most vaccinated countries in the world?
If they can prevent natural immunity for the sniffles as long as possible through fake temporary vaccines, we may be able to get mandatory mail in voting
Yes, they have learned that soaring rates keep people curled up In fear, and reliant on z d complaint with their abusers
I’m not getting any of their crap injected into my body. I don’t trust any of them; never will again.
I’m with you. Can’t figure out from the article if they are promoting this as health care or a stock market investment.
bkmk
Still Spike centric.
Novavax boosters haven’t been mentioned ... yet.
It works on meteorites! The numbers prove it. Nobody who took the J&J and a booster got killed by a meteorite that we know of. It totally works!!!
Great news! Does this mean Brandon will stop blocking Novavax in the U.S. before the 2024 elections?
Good news? Isn’t Omicron almost over?
RE: Good news? Isn’t Omicron almost over?
It hasn’t reached its peak in the USA like it has in South Africa. But we’ll get there... which means Novavax will be late in the game in the U.S.
Where’s the ‘mo money’ meme?
So funny!
They keep finding more and more uses for aborted babies
How could no word on a New Variant are they saving it ?
By the time Novavax gets FDA approval Omicron will be long, long forgotten.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.